Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.

Faculty

J. Fernando Arevalo, MD, PhD

Chairman of the Board of the Pan-American Ophthalmological Foundation
The Edmund and Virginia Ball Professor of Ophthalmology
Chairman of Ophthalmology at Johns Hopkins Bayview Medical Center
Johns Hopkins University
Wilmer Eye Institute
Baltimore, Maryland

Disclosures

Participation by Dr Arevalo does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

J. Fernando Arevalo, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Alimera Sciences; DORC; EyePoint Pharmaceuticals; Genentech, Inc.; Laboratoires Théa
Research funding from: Topcon Medical Systems Inc.

Jorge Fortun, MD

Associate Professor of Clinical Ophthalmology
Medical Director
Bascom Palmer Eye Institute, Palm Beach Gardens
University of Miami Health System
Miami, Florida

Disclosures

Jorge Fortun, MD, has the following relevant financial relationships:
Consultant or advisor for: Alcon Laboratories Corp.; Alimera Sciences; Allergan, Inc.; Apellis Pharmaceuticals; BVI; Carl Zeiss; DORC; EyePoint Pharmaceuticals; Iveric Bio
Research funding from: Aldeyra Therapeutics, Inc.; Alimera Sciences; Apellis Pharmaceuticals; Genentech, Inc.; Iveric Bio

Rishi Singh, MD

Staff Physician and President
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Stuart, Florida
Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio

Disclosures

Rishi Singh, MD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Alcon Laboratories Corp.; Apellis Pharmaceuticals; AsclepiX Therapeutics; Bausch + Lomb Inc.; Genentech, Inc.; Gyroscope; Iveric Bio; Novartis; Regeneron Pharmaceuticals, Inc.
Speaker or member of speakers bureau for: Apellis Pharmaceuticals; Genentech, Inc.; Regeneron Pharmaceuticals, Inc.

Editor

Pakinam Aboulsaoud, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME

Aiming for Equity: Best Practices in Managing Diabetic Eye Disease in Hispanic and Latino Patients

Authors: J. Fernando Arevalo, MD, PhD; Jorge Fortun, MD; Rishi Singh, MD
CME Released: 3/24/2023
Valid for credit through: 3/24/2024, 11:59 PM EST

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

Optometry - This course is COPE approved for 0.5 hours of CE credit.

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for ophthalmologists (primary audience), diabetologists/endocrinologists, and optometrists.

The goal of this activity is for learners to be better able to describe nuances of disease development and progression in Hispanic and Latino patients so that they can more effectively address the health crisis that this population continues to face.

At the conclusion of this program learners will be better able to:

Describe the unmet need for improved diabetic eye care in the Latino/Hispanic community
Outline the screening guidelines for diabetic eye disease
Weigh the benefits of timely treatment for patients with diabetic eye disease
Develop and communicate strategies that help support Latino/Hispanic patients with diabetic eye disease

Disclosures

Disclosures for additional planners can be found here.

Faculty

J. Fernando Arevalo, MD, PhD

Chairman of the Board of the Pan-American Ophthalmological Foundation
The Edmund and Virginia Ball Professor of Ophthalmology
Chairman of Ophthalmology at Johns Hopkins Bayview Medical Center
Johns Hopkins University
Wilmer Eye Institute
Baltimore, Maryland

Disclosures

Participation by Dr Arevalo does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

J. Fernando Arevalo, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Alimera Sciences; DORC; EyePoint Pharmaceuticals; Genentech, Inc.; Laboratoires Théa
Research funding from: Topcon Medical Systems Inc.

Jorge Fortun, MD

Associate Professor of Clinical Ophthalmology
Medical Director
Bascom Palmer Eye Institute, Palm Beach Gardens
University of Miami Health System
Miami, Florida

Disclosures

Jorge Fortun, MD, has the following relevant financial relationships:
Consultant or advisor for: Alcon Laboratories Corp.; Alimera Sciences; Allergan, Inc.; Apellis Pharmaceuticals; BVI; Carl Zeiss; DORC; EyePoint Pharmaceuticals; Iveric Bio
Research funding from: Aldeyra Therapeutics, Inc.; Alimera Sciences; Apellis Pharmaceuticals; Genentech, Inc.; Iveric Bio

Rishi Singh, MD

Staff Physician and President
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Stuart, Florida
Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio

Disclosures

Rishi Singh, MD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Alcon Laboratories Corp.; Apellis Pharmaceuticals; AsclepiX Therapeutics; Bausch + Lomb Inc.; Genentech, Inc.; Gyroscope; Iveric Bio; Novartis; Regeneron Pharmaceuticals, Inc.
Speaker or member of speakers bureau for: Apellis Pharmaceuticals; Genentech, Inc.; Regeneron Pharmaceuticals, Inc.

Editor

Pakinam Aboulsaoud, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

Developed through a partnership between the Postgraduate Institute for Medicine and Medscape.

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

For Optometrists

In support of improving patient care, Postgraduate Institute for Medicine (PIM) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation: Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists.

Credit Statement: This course is COPE approved for 0.5 hours of CE credit. Activity #125781 and Course ID 83885-PB. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.

Contact this provider www.pimed.com

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

Optometrists

In order to obtain your CME/CE certificate, please follow the steps below at the conclusion of the activity:

Go to www.cmeuniversity.com
Login or Create a New Account (will take less than 1 minute).
a. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email.

b. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page.
Type in 17834 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter.
Click on the activity title when it appears.
Choose the type of credit you desire.
Complete the online assessment.
Receive an immediate CME/CE Certificate to download and/or print for your files.

If you have questions regarding the certification of this activity, please contact PIM via email at [email protected]

From Medscape Education Ophthalmology

CME

Aiming for Equity: Best Practices in Managing Diabetic Eye Disease in Hispanic and Latino Patients

Authors: J. Fernando Arevalo, MD, PhD; Jorge Fortun, MD; Rishi Singh, MDFaculty and Disclosures

CME Released: 3/24/2023

Valid for credit through: 3/24/2024, 11:59 PM EST

processing....

Select Any Chapter to Begin

Patient Handout

Page 1 of 17

Unmet Needs and Risks in the Latino/Hispanic Population - Pre-Assessment

Earn Credit CME Information Download Slides

Activity Transcript

PDF Downloads

Patient Handout

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

J. Fernando Arevalo, MD, PhD

Jorge Fortun, MD

Rishi Singh, MD

Editor

Pakinam Aboulsaoud, PharmD

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

CME

Aiming for Equity: Best Practices in Managing Diabetic Eye Disease in Hispanic and Latino Patients

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

J. Fernando Arevalo, MD, PhD

Jorge Fortun, MD

Rishi Singh, MD

Editor

Pakinam Aboulsaoud, PharmD

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Optometrists

Instructions for Participation and Credit

Optometrists

Aiming for Equity: Best Practices in Managing Diabetic Eye Disease in Hispanic and Latino Patients

Select Any Chapter to Begin

Patient Handout

PDF Downloads